# Neuralink — Healthcare Company Profile

> other · Series C+. MedFuel Intel factual profile as of 2026-08-27.

## Key facts (as of 2026-08-27)
- Sector: other
- Stage: Series C+
- Website: https://neuralink.com

## MedFuel coverage
- MedFuel analyses on file: 1
- Full diligence report: available at https://www.medfuelintel.com/company/neuralink-18

## Run your own diligence
Get a free AI Red Flag Screener on Neuralink (FDA status, IP, financing, management, and risks, each tied to a primary source) at https://www.medfuelintel.com/screener?company=Neuralink

---
Source: MedFuel Intel — https://www.medfuelintel.com/company/neuralink-18. Compiled from public sources and automated analysis; it may be incomplete or inaccurate and is not affiliated with or endorsed by Neuralink. Factual profile only, not investment advice or a recommendation. Verify against primary sources (SEC, FDA, ClinicalTrials.gov) before any investment decision. Corrections or removal requests: media@medfuelinc.com.